VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6420
+0.0053 (0.83%)
May 1, 2026, 2:32 PM EDT - Market open
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $21.39 million as of May 1, 2026. Its market cap has decreased by -22.72% in one year.
Market Cap
21.39M
Enterprise Value
-7.79M
1-Year Change
-22.72%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $21.39M, a decrease of -90.69%. That is a compound annual growth rate of -32.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 21.22M | 9.88% |
| Dec 31, 2025 | 19.31M | -60.93% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 23.95M |
| Marker Therapeutics | 23.68M |
| AEON Biopharma | 23.53M |
| Vistagen Therapeutics | 22.98M |
| Serina Therapeutics | 22.78M |
| Curis | 22.40M |
| Exicure | 21.10M |
| Allarity Therapeutics | 20.88M |